Frankfurt - Delayed Quote EUR
Sangamo Therapeutics, Inc. (GBY.F)
0.3775
+0.0290
+(8.32%)
At close: May 16 at 9:39:12 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-44,625
-67,139
-224,842
-223,627
-233,251
Investing Cash Flow
1,684
37,524
153,531
59,285
248,199
Financing Cash Flow
14,389
28,377
14,588
84,660
32,858
End Cash Position
26,781
43,418
46,704
101,944
180,372
Capital Expenditure
--
-267
-21,155
-20,171
-23,278
Issuance of Capital Stock
16,828
28,991
15,106
84,869
27,099
Free Cash Flow
-44,892
-67,406
-245,997
-243,798
-256,529
12/31/2021 - 4/14/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BVNKF Bavarian Nordic A/S
26.80
0.00%
TRAW Traws Pharma, Inc.
1.1900
+6.25%
PLRX Pliant Therapeutics, Inc.
1.3800
+0.73%
PALI Palisade Bio, Inc.
0.6868
+0.99%
VRPX Virpax Pharmaceuticals, Inc.
0.2200
-12.00%
SPRC SciSparc Ltd.
0.3159
+3.24%
ZVSA ZyVersa Therapeutics, Inc.
0.5229
-0.21%
MREO Mereo BioPharma Group plc
2.2400
+2.75%
NKGN NKGen Biotech, Inc.
0.3498
+2.58%
GOSS Gossamer Bio, Inc.
1.0400
-0.95%